Key Highlights
- Jo Goodman appointed as VP of Bioanalytical Services at Celerion’s Lincoln, Nebraska laboratory.
- Goodman brings over 29 years of pharmaceutical experience, with past roles at AstraZeneca, MedImmune, and GlaxoSmithKline.
- Recognized for her contribution to the ICH M10 Bioanalytical Guidance Development and involvement in several non-profit industry consortia.
Source: Business Wire
Notable Quote
- “We are delighted to welcome Jo Goodman to our team. Her proven track record of leadership, globally recognized reputation, and expertise in bioanalytical services will be invaluable as we continue to expand our capabilities and provide superior solutions to our clients,” – Dr. Chad Briscoe, Executive Vice President of Global Bioanalytical Services at Celerion
SoHC's Take
Celerion’s recent appointment of Jo Goodman as the Vice President of Bioanalytical Services underscores a strategic move to bolster its leadership within the bioanalytical sector. With Goodman’s extensive background and leadership in pharmaceutical research and development, particularly in regulated bioanalysis, she is poised to drive forward Celerion’s commitment to industry-leading science and innovation. This addition to the team aligns with Celerion’s long-standing mission of accelerating drug development processes and enhancing service delivery to meet client demands more effectively. Goodman’s active role in notable industry consortia and her influence in global bioanalytical guidance development highlight her capacity to lead Celerion’s efforts in adapting to and shaping future industry standards and practices.
